Viewing Study NCT02049450


Ignite Creation Date: 2025-12-24 @ 5:10 PM
Ignite Modification Date: 2026-02-28 @ 11:20 AM
Study NCT ID: NCT02049450
Status: COMPLETED
Last Update Posted: 2017-07-17
First Post: 2014-01-28
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of Efficacy and Safety of INC424 in Regularly Transfused Patients With Thalassemia.
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Thalassemia Major View
Keywords:

Keywords

Keyword Brief Keyword Text View
None thalassemia View
None thalassemia major View
None spleen enlargement View
None INC424 View
None ruxolitinib View